bioRxivImmunologyPreprint
Progressive deterioration of adaptive immune repertoires in Down syndrome linked to interferon hyperactivity and lymphoid tissue disorganization
Micah G. DonovaniD, Neetha Paul EduthaniD, Brian F. NiemeyeriD, Elena WoodsiD, Eric Hoffmeyer, Natália JaegeriD, Eleanor C. Britton, Bartosz J. GrzywacziD, Joseph J. Fernandez, Galileo S. DumontiD, Brian William HerrmanniD, Norman R. FriedmaniD, Dallas Jones, Zdeněk AndrysíkiD, Angela L. RachubinskiiD, Kelly D. SullivaniD, Matthew D. GalbraithiD, Michael R. VernerisiD, Joaquin Maximiliano EspinosaiD
Abstract
Persons with Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), display strong dysregulation of adaptive immunity, which underlies high risk of complications from infections, widespread autoimmunity, and poor vaccine responses. However, the mechanisms by which T21 dysregulates adaptive immunity across the lifespan remain poorly understood. We report here a multimodal analysis of adaptive immunity across development and aging in DS, including deep B cell profiling by mass cytometry matched to transcriptome and proteome data, B and T cell receptor sequencing (BCR, TCR), and spatial transcriptomics of tonsil tissue. T21 causes progressive shifts in B cell subsets together with accelerated age-dependent B cell loss linked to hyperactive interferon and JAK/STAT signaling. The peripheral immunoglobulin repertoire shows dysregulated class switching, progressive loss of diversity, differential VDJ usage, and imbalanced rates of somatic hypermutation across immunoglobulin isotypes mirrored by contraction and skewing of the TCR repertoire. In children with DS, tonsil tissues are highly disorganized with smaller germinal centers, fibrotic intrusions, lower rates of cell proliferation, strong inflammatory signaling, and transcriptional programs indicative of dysregulated lymphocyte homing and residence. Together, these results point to hyperactive interferon signaling as a driver of dysregulated adaptive immunity in DS amenable to early therapeutic intervention.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- assay: spatial transcriptomics
- assay: CITE-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Altered follicular immunity in secondary lymphoid organs is associated with interferon hyperactivity in Down syndrome
Jeremías Dutto, Jeremías Bustos, … Mariana Maccioni·bioRxiv·Aug 9, 2026
- JAK inhibition decreases the autoimmune burden in Down syndrome
Angela L. Rachubinski, Elizabeth B. Wallace, … Joaquin Maximiliano Espinosa·eLifePeer-reviewed·Dec 31, 2024
- Permutational immune analysis reveals architectural similarities between inflammaging, Down syndrome and autoimmunity
K. Lambert, K. G. Moo, … B. Khor·bioRxiv·Sep 13, 2021
- Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
R. K. Powers, K. D. Sullivan, … J. M. Espinosa·bioRxiv·Jan 11, 2019
- Dysregulated airway epithelial antiviral immunity in Down Syndrome impairs type III IFN response and amplifies airway inflammation during RSV infection.
Elizabeth A. Chorvinsky, Surajit Bhattacharya, … Gustavo Niño·American Journal of Respiratory Cell and Molecular BiologyPeer-reviewed·Jun 30, 2025
- Coordinated immune dysregulation in Juvenile Dermatomyositis revealed by single-cell genomics
G. Rabadam, C. Wibrand, … J. Neely·bioRxiv·Nov 7, 2023